BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 17785329)

  • 1. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases.
    Ghillani P; Rouquette AM; Desgruelles C; Hauguel N; Le Pendeven C; Piette JC; Musset L
    Ann N Y Acad Sci; 2007 Aug; 1109():407-13. PubMed ID: 17785329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
    Desplat-Jego S; Bardin N; Larida B; Sanmarco M
    Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of antinuclear antibody connective tissue disease screen.
    López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
    Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel method for quantitative ANA measurement using near-infrared imaging.
    Peterson LK; Wells D; Shaw L; Velez MG; Harbeck R; Dragone LL
    J Immunol Methods; 2009 Sep; 349(1-2):1-8. PubMed ID: 19720064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and identification of significant ANAs in previously determined ANA negative samples.
    Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
    Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies.
    Shovman O; Gilburd B; Barzilai O; Shinar E; Larida B; Zandman-Goddard G; Binder SR; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1050():380-8. PubMed ID: 16014555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of autoantibodies to nuclear antigens by EIA and IF techniques.
    Alem M; Moghadam S; Malki J; Zaidi A; Nayak N; Li TM
    Allerg Immunol (Paris); 1997 Sep; 29(7):188, 191-4. PubMed ID: 9373708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
    Chopra A; Anuradha V; Edmonds J
    J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HEp2 ANA EIA: a new fully automated assay for the screening of antinuclear antibodies.
    Lehmann HP; Fühling I; Ott C; Hüdepohl B; Haass M
    Isr Med Assoc J; 2000 Aug; 2(8):646-8. PubMed ID: 10979370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
    Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
    Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.
    Nifli AP; Notas G; Mamoulaki M; Niniraki M; Ampartzaki V; Theodoropoulos PA; Kopnitsky MJ; Castanas E
    J Immunol Methods; 2006 Apr; 311(1-2):189-97. PubMed ID: 16554066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera.
    Copple SS; Martins TB; Masterson C; Joly E; Hill HR
    Ann N Y Acad Sci; 2007 Aug; 1109():464-72. PubMed ID: 17785335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.
    Mahler M; Hanly JG; Fritzler MJ
    Autoimmun Rev; 2012 Jul; 11(9):642-5. PubMed ID: 22100330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
    González Rodríguez C; Fuentes Cantero S; Pérez Pérez A; Vázquez Barbero FJ; León Justel A
    J Clin Lab Anal; 2021 Sep; 35(9):e23914. PubMed ID: 34347308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
    Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
    J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening tests for antinuclear antibodies (ANA): selective use of central nuclear antigens as a rational basis for screening by ELISA.
    Olaussen E; Rekvig OP
    J Autoimmun; 1999 Aug; 13(1):95-102. PubMed ID: 10441173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.
    Remmel T; Piirsoo A; Koiveer A; Remmel H; Uibo R; Salupere V
    Hepatogastroenterology; 1996; 43(11):1135-40. PubMed ID: 8908541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.